"estrogen receptor pathway" trang 10 - tải miễn phí từ tailieunhanh
NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer
13    52    1
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
14    45    1
Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells

Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells
17    48    1
Bài giảng Điều trị mãn kinh liệu pháp hormone và không hormone

Bài giảng Điều trị mãn kinh liệu pháp hormone và không hormone
53    67    2
Can we use gonadotropin plasma concentration as surrogate marker for BMIrelated incomplete estrogen suppression in breast cancer patients receiving anastrozole?

Can we use gonadotropin plasma concentration as surrogate marker for BMIrelated incomplete estrogen suppression in breast cancer patients receiving anastrozole?
7    50    1
Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: A retrospective clinical study

Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: A retrospective clinical study
7    62    1
IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells

IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells
11    31    1
Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy

Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy
7    69    1
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures

The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures
11    36    1
Atypical ubiquitin ligase RNF31: The nuclear factor modulator in breast cancer progression

Atypical ubiquitin ligase RNF31: The nuclear factor modulator in breast cancer progression
8    78    1
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
8    63    1
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma

HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
15    71    1
Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration

Aggressive breast cancer in western Kenya has early onset, high proliferation, and immune cell infiltration
15    36    1
Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer
13    62    1
Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: A focus group study

Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: A focus group study
8    53    1
Using second harmonic generation to predict patient outcome in solid tumors

Using second harmonic generation to predict patient outcome in solid tumors
10    44    1
Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial
8    55    1
Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival

Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival
9    44    1
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
11    59    1
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13

Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13
12    27    1